ShowcasesPricing
  1. US-listed companies
  2. KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc.KALV

Market cap
$415.25M
P/E ratio
Income statementBalance sheetCash flowOther
Raw aggregated data